Lab
Clinical Laboratory Services of Manati, INC
Clinical Laboratory Services of Manati, INC was paid $1.49M by Medicaid between Jan 2018 and Nov 2024, across 58 billing codes. Its largest line is 87426, Infectious agent antigen detection, SARS-CoV-2 (COVID-19) — 13% of everything it billed.
33Billing provider infoCLINICAL LABORATORY SERVICES OF MANATI, INC
MANATI, PR 00674
MANATI, PR 00674
33aNPI1619115755assigned 01/28/2009
33bProvider typeClinical Medical Laboratory
28Total paid$1.49M
24GClaims144,341
24DCodes billed58
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#80 of 777
Median peer was paid$278K
This provider vs. median5.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 20,675 | $165K | |
| 2019 | 13,959 | $100K | |
| 2020 | 17,247 | $158K | |
| 2021 | 25,549 | $309K | |
| 2022 | 25,890 | $353K | |
| 2023 | 21,615 | $217K | |
| 2024incomplete | 19,406 | $192K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 13% | 4,653 | 4,307 | $191K |
| 84443 | Thyroid stimulating hormone (TSH) | 12% | 11,682 | 11,185 | $181K |
| 80061 | Lipid panel | 9.2% | 10,933 | 10,467 | $137K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 7.9% | 4,924 | 4,534 | $119K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 7.9% | 16,359 | 15,316 | $118K |
| 80053 | Comprehensive metabolic panel | 7.6% | 11,619 | 11,019 | $114K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 5.6% | 3,043 | 2,886 | $84K |
| 83036 | Hemoglobin; glycosylated (A1C) | 4.5% | 7,503 | 7,158 | $67K |
| 82274 | 3.6% | 3,595 | 3,436 | $53K | |
| 36415 | Collection of venous blood by venipuncture | 3.5% | 19,439 | 17,767 | $53K |
| 81000 | 2.6% | 13,305 | 12,600 | $39K | |
| 86328 | 2.1% | 1,352 | 1,231 | $32K |
46 more codes
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.7% | 3,776 | $25K |
| 84153 | 1.6% | 1,387 | $23K | |
| 86738 | 1.3% | 1,496 | $19K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.2% | 352 | $18K |
| 82043 | 1.2% | 3,012 | $17K | |
| 87276 | 1.1% | 1,308 | $17K | |
| 87275 | 1.1% | 1,307 | $16K | |
| 87088 | 1.1% | 2,179 | $16K | |
| 86701 | 1.0% | 1,682 | $16K | |
| 82570 | <1% | 3,103 | $15K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,862 | $15K |
| 82607 | <1% | 1,035 | $15K | |
| 84480 | <1% | 987 | $13K | |
| 84439 | <1% | 1,406 | $13K | |
| 84436 | <1% | 1,772 | $11K | |
| 80074 | <1% | 218 | $10K | |
| 85651 | <1% | 3,284 | $10K | |
| 86592 | <1% | 1,604 | $6K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 181 | $6K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 183 | $6K |
| 85730 | <1% | 568 | $3K | |
| 85610 | <1% | 649 | $2K | |
| 84479 | <1% | 376 | $2K | |
| 86038 | <1% | 112 | $1K | |
| 85027 | <1% | 205 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 84 | $1K |
| 83970 | <1% | 25 | $1K | |
| 82950 | <1% | 204 | $892.41 | |
| 86696 | <1% | 34 | $634.58 | |
| 86803 | <1% | 39 | $593.53 | |
| 82947 | <1% | 151 | $534.31 | |
| 86710 | <1% | 35 | $450.30 | |
| 86140 | <1% | 92 | $381.75 | |
| 82465 | <1% | 89 | $359.31 | |
| 86695 | <1% | 22 | $290.16 | |
| 87490 | <1% | 13 | $289.44 | |
| 87273 | <1% | 21 | $248.24 | |
| 87274 | <1% | 21 | $248.24 | |
| 87186 | <1% | 30 | $247.50 | |
| 84478 | <1% | 44 | $237.99 | |
| 83001 | <1% | 12 | $210.00 | |
| 80050 | General health panel | <1% | 17 | $167.69 |
| 87177 | <1% | 18 | $115.71 | |
| 84550 | <1% | 12 | $54.60 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 388 | $0.08 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 539 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMORALES, ELLIOT (PRESIDENT)